Get the Stockscreener App
31.49
1.22%
-0.3711
Ideaya Biosciences Inc stock is traded at $31.49, with a volume of 568.88K.
It is down -1.22% in the last 24 hours and up +13.86% over the past month.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
See More
Previous Close:
$31.86
Open:
$31.76
24h Volume:
568.88K
Relative Volume:
0.47
Market Cap:
$2.76B
Revenue:
$23.38M
Net Income/Loss:
$-155.22M
P/E Ratio:
-14.38
EPS:
-2.19
Net Cash Flow:
$-134.36M
1W Performance:
-2.78%
1M Performance:
+13.86%
6M Performance:
+50.36%
1Y Performance:
+10.03%
1-Day Range:
$30.57
$32.02
1-Week Range:
$30.57
$33.64
52-Week Range:
$13.45
$33.64
Ideaya Biosciences Inc Stock (IDYA) Company Profile
Name
Ideaya Biosciences Inc
Sector
Industry
Phone
650-443-6209
Address
5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA
Compare IDYA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IDYA
Ideaya Biosciences Inc
|
31.46 | 2.79B | 23.38M | -155.22M | -134.36M | -2.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.52 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.42 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
431.79 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.21 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.05 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Ideaya Biosciences Inc Stock (IDYA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-18-25 | Initiated | Guggenheim | Buy |
| Sep-04-25 | Initiated | Barclays | Overweight |
| Sep-04-25 | Initiated | Citizens JMP | Mkt Outperform |
| Jul-22-25 | Initiated | TD Cowen | Buy |
| Jul-10-25 | Resumed | Goldman | Neutral |
| Jun-26-25 | Initiated | Wells Fargo | Overweight |
| Nov-18-24 | Initiated | Stephens | Overweight |
| Nov-05-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Oct-24-24 | Initiated | UBS | Buy |
| Oct-15-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-08-24 | Initiated | Mizuho | Outperform |
| Mar-08-24 | Initiated | BTIG Research | Buy |
| Aug-08-23 | Initiated | SVB Securities | Outperform |
| May-24-23 | Initiated | Goldman | Buy |
| Apr-24-23 | Upgrade | Stifel | Hold → Buy |
| Mar-23-23 | Initiated | Berenberg | Buy |
| Feb-28-23 | Initiated | RBC Capital Mkts | Outperform |
| Dec-28-22 | Initiated | CapitalOne | Overweight |
| Oct-27-22 | Initiated | Citigroup | Buy |
| Aug-15-22 | Downgrade | Stifel | Buy → Hold |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Mar-10-22 | Upgrade | Stifel | Hold → Buy |
| Sep-23-21 | Initiated | Stifel | Hold |
| Jun-04-21 | Resumed | Robert W. Baird | Outperform |
| Mar-11-21 | Initiated | Guggenheim | Buy |
| Oct-07-20 | Initiated | Wedbush | Outperform |
| Sep-01-20 | Initiated | Northland Capital | Outperform |
| Jul-13-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Jun-17-20 | Reiterated | H.C. Wainwright | Buy |
| Apr-06-20 | Initiated | H.C. Wainwright | Buy |
| Mar-13-20 | Initiated | ROTH Capital | Buy |
| Oct-17-19 | Initiated | Oppenheimer | Outperform |
| Sep-10-19 | Initiated | Robert W. Baird | Outperform |
| Jun-17-19 | Initiated | Citigroup | Buy |
| Jun-17-19 | Initiated | JP Morgan | Neutral |
| Jun-17-19 | Initiated | Jefferies | Buy |
View All
Ideaya Biosciences Inc Stock (IDYA) Latest News
Using AI based signals to follow IDEAYA Biosciences Inc.Weekly Loss Report & Reliable Entry Point Trade Alerts - newser.com
Is IDEAYA Biosciences Inc. stock a top momentum play2025 Analyst Calls & Real-Time Chart Breakout Alerts - newser.com
Why IDEAYA Biosciences Inc. stock appeals to analystsDividend Hike & Accurate Entry/Exit Alerts - newser.com
How IDEAYA Biosciences Inc. stock reacts to Fed rate cuts2025 Earnings Surprises & Stepwise Trade Signal Implementation - newser.com
Will IDEAYA Biosciences Inc. (30J) stock extend growth story2025 Market Overview & Long-Term Growth Portfolio Plans - newser.com
Will IDEAYA Biosciences Inc. stock see PE expansion2025 Key Lessons & Weekly Top Gainers Trade List - newser.com
IDEAYA Biosciences Inc. stock trend forecastEarnings Growth Report & Stepwise Entry/Exit Trade Alerts - newser.com
Can IDEAYA Biosciences Inc. stock sustain revenue growthWeekly Stock Analysis & Daily Growth Stock Investment Tips - newser.com
What MACD signals say about IDEAYA Biosciences Inc.Watch List & Real-Time Volume Trigger Notifications - newser.com
IDEAYA Biosciences to Participate in Upcoming November 2025 Investor Relations Events - Sahm
Is IDEAYA Biosciences Inc. stock in correction or buying zoneWeekly Risk Report & Consistent Profit Alerts - newser.com
Order flow analysis tools used on IDEAYA Biosciences Inc.2025 Market Sentiment & Safe Entry Trade Reports - newser.com
AlphaQuest LLC Sells 16,763 Shares of IDEAYA Biosciences, Inc. $IDYA - MarketBeat
Will IDEAYA Biosciences Inc. stock remain a Wall Street favoriteMarket Volume Report & Weekly High Momentum Picks - newser.com
IDEAYA Biosciences (NASDAQ:IDYA) Upgraded at Wall Street Zen - MarketBeat
Using flow based indicators on IDEAYA Biosciences Inc.July 2025 Pullbacks & Short-Term Swing Trade Alerts - newser.com
IDEAYA Biosciences (NASDAQ: IDYA) awards 73,500 inducement options with 4-year vesting - Stock Titan
Visualizing IDEAYA Biosciences Inc. stock with heatmapsJuly 2025 Selloffs & Detailed Earnings Play Strategies - newser.com
Can IDEAYA Biosciences Inc. (30J) stock attract ESG investmentsMarket Activity Recap & Real-Time Market Trend Scan - newser.com
How to integrate IDEAYA Biosciences Inc. into portfolio analysis toolsSwing Trade & Real-Time Market Sentiment Reports - newser.com
Clinical Trial Success Propels Ideaya Biosciences Shares to New Heights - AD HOC NEWS
Institutional scanner results for IDEAYA Biosciences Inc.Trade Analysis Summary & AI Enhanced Market Trend Forecasts - newser.com
Why IDEAYA Biosciences Inc. (30J) stock benefits from AI revolutionWeekly Stock Analysis & Low Risk Growth Stock Ideas - newser.com
Is IDEAYA Biosciences Inc. stock entering bullish territoryOil Prices & Verified Swing Trading Watchlist - newser.com
State of New Jersey Common Pension Fund D Increases Stock Holdings in IDEAYA Biosciences, Inc. $IDYA - MarketBeat
Will IDEAYA Biosciences Inc. (30J) stock beat revenue estimatesEarnings Beat & Precise Buy Zone Identification - newser.com
Published on: 2025-10-30 01:22:11 - newser.com
Ideaya Biosciences Inc Stock (IDYA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.27%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):